cd38 inhibitor synergy with nnmt inhibitor 5-amino-1mq nad+

cd38 inhibitor synergy with nnmt inhibitor 5-amino-1mq nad+ Nicotinamide N-Methyltransferase (NNMT) and Liver Cancer: From Metabolic Networks to Therapeutic Targets Heavy-chain antibody targeting of CD38

Name: cd38 inhibitor synergy with nnmt inhibitor 5-amino-1mq nad+ Nicotinamide N-Methyltransferase (NNMT) and Liver Cancer: From Metabolic Networks to Therapeutic Targets Heavy-chain antibody targeting of CD38
Brand: equiscorp.hu
SKU: 92044408022
Price: 20.43 USD
Availability: InStock
Rating: 4.4032 (11 reviews)

Heavy chain antibody targeting of CD38 NAD+ hydrolase ectoenzyme to prevent fibrosis in multiple organs Scientific Reports Nicotinamide N Methyltransferase in Cardiovascular Diseases: Metabolic Regulator and Emerging Therapeutic Target Nicotinamide N methyltransferase as a potential therapeutic target for neurodegenerative disorders: Mechanisms, challenges, and future directions ScienceDirect Complex roles of nicotinamide N methyltransferase in cancer progression PMC

SKU: 92044408022 · From equiscorp.hu

4.4

USD20.43 USD41.43

Pay in 4 interest-free payments of $5.11 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 3 - Aug 8

Description

Scientific Context| One compound that has attracted attention in metabolic and neurological research is Vitamin B12 (commonly cyanocobalamin or methylcobalamin), an essential nutrient involved in red blood cell formation, DNA synthesis, and energy metabolism

Most side effects from B12 shots resolve quickly, making them generally well-tolerated for routine supplementation

Moreover, B12 injections may contribute to cardiovascular health by helping to lower homocysteine levels, an amino acid associated with an increased risk of heart disease